向PI3K的Kongensin A通过调节巨细胞极化和缓解炎症信号来减轻炎症诱导的关节炎
Yuhui Guo1, Peng Wang2, Binwu Hu3
1Department of Orthopaedic Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China; Department of Orthopaedic Research Center, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
International immunopharmacology
|September 1, 2024
概括
康素A (KA) 通过减少炎症和软骨损伤,有效治疗骨关节炎 (OA). 它通过抑制PI3K/AKT/NF-κB通路,重编程巨细胞和减缓状细胞衰老而起作用.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 骨关节炎 (OA) 涉及由炎症驱动的软骨退化,M1巨细胞极化和软骨细胞衰老.
- 植物提取物Kongensin A (KA) 显示出抗炎作用的潜力,但其OA疗效尚不清楚.
研究的目的:
- 研究KA对炎症微环境,巨细胞极化,细胞外基质 (ECM) 代谢和OA中的冠状细胞衰老的影响.
- 阐明KA作用的潜在分子机制.
主要方法:
- 在体外研究细胞和巨细胞,包括条件介质 (CM) 实验.
- 在OA模型中KA的体内给药.
- 对炎症信号通路的分析,特别是PI3K/AKT/NF-κB.
主要成果:
- KA抑制了炎症信号和冠状细胞衰老.
- 卡维护了ECM稳态,并通过PI3K/AKT/NF-κB轴抑制了M1巨分极.
- 在体内,KA治疗缓解了软骨退化和OA进展.
结论:
- KA通过抑制PI3K/AKT/NF-κB通路来缓解OA,从而重编程巨细胞,平衡ECM新陈代谢,并减少胆细胞衰老.
- 凯恩提出了一个有前途的治疗候选人,用于骨关节炎治疗.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


